Pharmacists globally are broadening their roles to support self-care, aiming to enhance patient health outcomes through increased contributions and proactive
behaviours, according to a new report.
However, significant barriers, including inadequate funding and limited access to patient records, impede the optimisation of self-care activities and outcomes
improvement in this area, the International Pharmaceutical Federation (FIP) said in its report.
The FIP report, titled 'Community Pharmacy Insights: Supporting the Need for Self-Care,' gathers insights from 238 respondents across 55 countries with the aim
of providing evidence-based policy support for workforce development.
Nearly all respondents (93.2 per cent) indicated that pharmacists should actively engage in providing self-care support, FIP said. Furthermore, 48.9 per cent
supported the involvement of pharmacy technicians, while 39.2 per cent endorsed the participation of pharmacy assistants and other team members in offering
self-care support.
Global instant logistics leader, Zipline is partnering with UK drone delivery startup, Apian Aero to launch a drone delivery programme of critical medical
supplies for the Northumbria Healthcare NHS Foundation Trust.
The new service, expected to begin in the autumn of 2024, will see delivery of medical supplies to hospitals, GPs and care homes, using electric, autonomous drones.
Zipline announced the partnership on Sunday, and said drone delivery service will help provide timely access to prescription medicines, wound care products, joint
replacement implants, and other frequently ordered medical products, which could allow healthcare providers to reduce the number of cancelled procedures, and thus
decrease wait times.
Also, the expansion of the programme will help in creating local job opportunities in the region, it added.
In a bid to amplify the role of pharmacists in clinical services and vaccination programs, the Pharmacists' Defence Association (PDA) has embarked on a
groundbreaking collaboration with Aston University.
This initiative, funded by Innovate UK Business Connect, aims to explore the feasibility and impact of integrating additional healthcare interventions within
community pharmacies.
"The Knowledge Transfer Partnership (KTP) research project represents an exciting opportunity to advance the role of pharmacists in patient care," remarked
Alison Jones, Director of Policy at PDA.
"This project will be an important part of that evolution, supporting individual pharmacists to have more opportunities to practice and so develop more fulfilling
careers."
Led by the PDA and Aston University, the project will commence imminently, focusing on the Priory Community Pharmacy in Dudley.
NHS England will collaborate with "a number of system suppliers" to increase the number of trusts using electronic prescription service (EPS) over the next
few years.
Nishali Patel, clinical lead for digital medicines at NHS England, announced it during the Clinical Pharmacy Congress, held at the Excel, London, on Friday, 10 May
2024.
According to Nishali, at least half of all NHS secondary care trusts could be using EPS by 2026.
This digital service allows prescribers to send prescriptions electronically to a patient-nominated pharmacy. It is widely used in primary care, where over 95
per cent of prescriptions are now electronically generated. NHS recently extended the service to secondary care settings.
The National Health Service (NHS) is embracing new technology and innovations like artificial intelligence (AI) to reduce the number of missed hospital
appointments and improve waiting times for elective care.
Following a successful pilot in Mid and South Essex NHS Foundation Trust, the health service is set to roll out AI software to 10 more trusts across England in
the coming months.
The software, developed by Deep Medical in collaboration with a frontline worker and NHS clinical fellow, helps reduce the number of missed appointments by
offering patients convenient time slots and backup booking options.
Since the AI programme was piloted six months ago, Mid and South Essex NHS Foundation Trust has seen a 30 per cent fall in non-attendances.
During the pilot period, a total of 377 did not attends (DNAs) were prevented and an additional 1,910 patients were attended.
Aspire Pharma Limited has solidified its position as a leading specialty generics enterprise by adding leuprorelin acetate as a branded generic to its
oncology portfolio.
Leuprorelin acetate is hormone therapy recommended for patients with high-risk localised, locally advanced, and metastatic prostate cancer, serving as an
alternative to surgical castration for locally advanced cases.
Used as an alternative to surgical castration for locally advanced prostate cancer, a pre-filled syringe containing 11.25mg of leuprorelin acetate
(equivalent to 10.72 mg leuprorelin) is injected subcutaneously into the abdomen.
The British pharmaceutical company noted that one of its primary objectives is to seek "new investment opportunities" that brings products and companies into
its portfolio, aligning closely with Aspire values and therapeutic focus areas.
Prostate cancer is the most common cancer among men in the UK, with an average of over 52,000 men receiving a diagnosis of prostate cancer annually, as per
Prostate Cancer UK.
Specialist business property adviser, Christie & Co has confirmed that City Pharmacy in Portsmouth, Hampshire has been purchased by the existing regional
operator, JCL (U.K.) LTD - Lalys Pharmacy.
Nyewood Healthcare, which owned the community pharmacy for over 25 years, decided to sell the business to concentrate on their two remaining pharmacies in West
Sussex, the broker said.
Located on a busy parade in the North End area of Portsmouth, City Pharmacy dispenses an average of 6,900 items per month, it added.
Following a freehold sale, the business has been acquired by Lalys Pharmacy, which already has multiple other pharmacies in Hampshire, Dorset, and Surrey.
Raj Laly, Director at Lalys Pharmacy, commented: "We are delighted to continue the expansion of our group in Portsmouth as we currently operate right across
Hampshire, Surrey, and Dorset.
A recent study presented at the European Congress on Obesity in Venice sheds light on the detrimental effects of obesity on workplace absenteeism and economic
productivity.
The analysis, encompassing data from millions of workers across Europe, reveals a direct correlation between body mass index (BMI) and the likelihood of taking sick
leave.
According to the study, obese individuals are up to twice as likely to take time off work due to health issues compared to those of a healthy weight.
The increased sick notes among obese individuals is attributed to various complications associated with obesity, including joint pain, diabetes, depression, and
heart disease.
In the United Kingdom, where obesity rates are among the highest in Europe, the impact of obesity on workplace absenteeism is particularly pronounced.
The UK government has announced plans to update legislation to enable more services and individuals to provide take-home supplies of naloxone - a life-saving
opioid overdose antidote - over the next few weeks.
Naloxone can immediately reverse the effects of an opioid overdose by reversing breathing difficulties. The medicine can be administered by anyone in an emergency.
However, current legislation allows only drug and alcohol treatment services to supply it without a prescription to individuals for future use.
The Department of Health and Social Care (DHSC) confirmed on Tuesday (14 May) that more professionals, including nurses, paramedics, police officers, probation
officers and pharmacy professionals, will be able to supply the medicine without a prescription to save lives.
Health and Social Care Secretary Victoria Atkins warned that opioid addiction can ruin lives and it accounts for the largest proportion of drug-related deaths
across the UK.
"Patients deserve choice, but wherever they go they will find vacant nursing posts and overstretched services," responded Professor Pat Cullen, RCN
General Secretary and Chief Executive, to the introduction of the new pilot scheme for out-of-hospital patient care.
The NHSE and the DHSC have announced a new pilot scheme commencing in autumn "offering patients a choice of where they receive out-of-hospital care".
Under the initiative, individuals requiring treatment outside of hospitals will have the opportunity to select from a range of providers across both the NHS
and the independent sector.
Patients can select their care provider for in-hospital consultant-led services post-GP consultation, offering a choice from at least 5 providers with details
on waiting times, distance, and quality.
In a strategic move to enhance healthcare delivery, the NHS has announced plans to intensify the utilisation of virtual wards under the the Urgent and
Emergency Care Recovery Plan.
The NHS virtual wards are aimed to reduce avoidable hospital admissions across England.
This follows a comprehensive analysis revealing significant benefits from virtual wards over the past year.
"Virtual wards offer a transformative approach to healthcare delivery, allowing patients to receive medical care from the comfort of their own homes," remarked
NHS national director for urgent and emergency care, Sarah-Jane Marsh.
"This initiative not only reduces the burden on hospital resources but also ensures that patients receive timely and personalised care."
Superdrug is bolstering its physical presence by launching 25 new stores this year as it celebrates its 60th year on the British high street.
Additionally, the health and beauty retailer has announced plans to extend seven of its existing branches and refit another 60 throughout 2024.
However, the retailer has confirmed the locations for only four upcoming stores - Wheatley Centre Shopping Parkin Doncaster, St David's Centre in Cardiff,
Bluewater Shopping Centre and Westfield Stratford City.
As reported by Mirror, the Donacaster site is expected to open by the end of this month, followed by the relocation of its existing Cardiff store to a new
11,3000 sq. ft space shortly thereafter.
Superdrug is also shifting its Westfield Stratford City store, doubling its size to 9,892 sq. ft. Likely to be opened in the summer, it will be one of the
retailer's biggest stores.
Well Pharmacy, the UK's largest independent pharmacy chain, recently announced the opening of a new store inside WHSmith's flagship airside location at
Birmingham Airport.
This expansion is part of Well Pharmacy's ongoing collaboration with WHSmith, the global travel retailer.
Situated within the departure lounge of Birmingham Airport, the biggest and busiest airport in the Midlands and the seventh largest in the UK, the new pharmacy
will offer travelers a wide range of pharmacy products and expert healthcare services.
The new pharmacy complements WHSmith's extensive selection of health and beauty items, travel essentials, food-to-go, and tech products.
Andrew Caplan, chief retail officer at Well Pharmacy, expressed enthusiasm about the continued partnership.
"Well Pharmacy are delighted to continue to work in partnership with WHSmith in providing a one stop shop for all travellers' needs," he stated.